Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Rat (Rattus) Anticorps:
anti-Mouse (Murine) Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Human Polyclonal SLC25A20 Primary Antibody pour IHC, IHC (p) - ABIN4354141
Tachibana, Takeuchi, Inada, Yamasaki, Ishimoto, Tanaka, Hamakubo, Sakai, Kodama, Doi: Regulation of the human SLC25A20 expression by peroxisome proliferator-activated receptor alpha in human hepatoblastoma cells. dans Biochemical and biophysical research communications 2009
Cow (Bovine) Polyclonal SLC25A20 Primary Antibody pour WB - ABIN2781540
Pierre, Macdonald, Gray, Hendriksz, Preece, Chakrapani: Prospective treatment in carnitine-acylcarnitine translocase deficiency. dans Journal of inherited metabolic disease 2007
Human Polyclonal SLC25A20 Primary Antibody pour ICC, IF - ABIN4354140
Häggmark, Mikus, Mohsenchian, Hong, Forsström, Gajewska, Barańczyk-Kuźma, Uhlén, Schwenk, Kuźma-Kozakiewicz, Nilsson: Plasma profiling reveals three proteins associated to amyotrophic lateral sclerosis. dans Annals of clinical and translational neurology 2014
It has been shown that Dorsal repressed Ush expression levels to promote hemocytes differentiation, whereas Cactus maintained Ush levels to block differentiation.
CalpA targets free Cactus, which is incorporated into and modulates Toll (Montrer TLR4 Anticorps)-responsive complexes in the embryo and immune system.
Dorsal and Cactus maybe necessary for normal function and maintenance of the neuromuscular system. These proteins can respond to synaptic activity.
Cactus acts as an inhibitor of the Rel-transcription factors Dorsal and Dif (Montrer TNF Anticorps).
immune-induced degradation does not require CSN5 (Montrer COPS5 Anticorps)
Dpp signals increase Cactus levels through Calpain A inhibition, thereby interfering with Dorsal activation
we report the first 2 cases of CACTD identified from the mainland China. Apart from a founder mutation c.199-10T>G, we have identified a novel c.1A>G mutation. Patients with Carnitine-acylcarnitine translocase deficiency with a genotype of c.199-10T>G mutation usually presents with a severe clinical phenotype. Early recognition and appropriate treatment is crucial in this highly lethal disorder.
We provide evidence that the downregulation of hsa (Montrer CD24 Anticorps)-miR (Montrer MLXIP Anticorps)-124-3p, hsa (Montrer CD24 Anticorps)-miR (Montrer MLXIP Anticorps)-129-5p and hsa (Montrer CD24 Anticorps)-miR (Montrer MLXIP Anticorps)-378 induced an increase in both expression and activity of CPT1A (Montrer CPT1A Anticorps), CACT and CrAT (Montrer CRAT Anticorps) in malignant prostate cells.
The antiport mode of transport, typical of mitochondrial carriers such as CAC (Montrer CA2 Anticorps), results from coupling of uniport reactions in opposite directions mediated by specific amino acid residues.
C.576G>A, c.106-2a>t and c.516T>C are novel CACT gene mutations.
CPT2 (Montrer CPT2 Anticorps) and CACT are crucial for mitochondrial acylcarnitine formation and export to the extracellular fluids in mitochondrial fatty acid beta-oxidation disorders.
Compares and contrasts all the known human SLC25A (Montrer SLC25A25 Anticorps)* genes and includes functional information.
Results show Steroid Receptor Coactivator (Montrer SRA1 Anticorps)-3 (SRC-3 (Montrer NCOA3 Anticorps)) plays a central role in long chain fatty acid metabolism by directly regulating carnitine/acyl-carnitine translocase (CACT) gene expression.
These results show that FOXA and Sp1 (Montrer PSG1 Anticorps) sites in HepG2 cells and only the Sp1 (Montrer PSG1 Anticorps) site in HEK293 and SK-N-SH cells have a critical role in the transcriptional regulation of the CAC (Montrer CA2 Anticorps) proximal promoter.
A deficiency in CACT was treated with a carnitine diet and administration of medium-chain triglycerides.
The clinical, biochemical, & molecular features of 6 CACT-deficient patients from Italy, Spain, & North America who had significant clinical heterogeneity are reported. 5 novel & 3 previously reported mutations were found.
the 50-flanking region of the Cact gene contains a consensus sequence for ERRalpha (Montrer ESRRA Anticorps). This sequence binds ERRa (Montrer ESRRA Anticorps) both in vivo and in vitro and is required for the activation of Cact expression by the PGC-1/ERR (Montrer SLC7A1 Anticorps) axis
Data show that the upregulation of CACT by PPARalpha (Montrer PPARA Anticorps) and PPARdelta (Montrer PPARD Anticorps) may increase the import of acylcarnitine into the mitochondrial matrix during fasting.
This gene product is one of several closely related mitochondrial-membrane carrier proteins that shuttle substrates between cytosol and the intramitochondrial matrix space. This protein mediates the transport of acylcarnitines into mitochondrial matrix for their oxidation by the mitochondrial fatty acid-oxidation pathway. Mutations in this gene are associated with carnitine-acylcarnitine translocase deficiency, which can cause a variety of pathological conditions such as hypoglycemia, cardiac arrest, hepatomegaly, hepatic dysfunction and muscle weakness, and is usually lethal in new born and infants.
, NF-kappa-B inhibitor cactus
, solute carrier family 25 (carnitine/acylcarnitine translocase), member 20
, carnitine/acylcarnitine translocase
, mitochondrial carnitine/acylcarnitine carrier protein
, solute carrier family 25 (mitochondrial carnitine/acylcarnitine translocase), member 20
, solute carrier family 25 member 20
, protein kinase, cAMP-dependent, regulatory, type II, alpha
, carnitine/acylcarnitine carrier protein
, mitochondrial carnitine-acylcarnitine translocase